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Background: The molecular determinants of carcinogenesis, tumor progression and patient 
prognosis can be deduced from simultaneous comparison of thousands of genes by microarray 
analysis. However, the presence of stroma cells in surgically excised carcinoma tissues might 
obscure the tumor cell-specific gene expression profiles of these samples. To circumvent this 
complication, laser microdissection can be performed to separate tumor epithelium from the 
surrounding stroma and healthy tissue. In this report, we compared RNAs isolated from 
macrodissected, of which only surrounding healthy tissue had been removed, and microdissected 
rectal carcinoma samples by microarray analysis in order to determine the most reliable approach 
to detect the expression of tumor cell-derived genes by microarray analysis.
Results: As microdissection yielded low tissue and RNA quantities, extra rounds of mRNA 
amplification were necessary to obtain sufficient RNA for microarray experiments. These second 
rounds of amplification influenced the gene expression profiles. Moreover, the presence of stroma 
cells in macrodissected samples had a minor contribution to the tumor cell gene expression 
profiles, which can be explained by the observation that more RNA is extracted from tumor 
epithelial cells than from stroma.
Conclusion: These data demonstrate that the more convenient procedure of macrodissection 
can be adequately used and yields reliable data regarding the identification of tumor cell-specific 
gene expression profiles.
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Background
Microarray technology permits simultaneous analyses of 
the expression profiles of thousands of genes. These anal­
yses allow identification of profiles correlating with prog­
nosis and permit tumor classifications [1-3], but can also 
be used to identify genes that are involved in several 
molecular processes, like carcinogenesis, metastasis and 
responses to treatment (reviewed by ref [4]).
To ensure that the expressions of tumor cell-derived genes 
are identified by microarray analysis of surgically excised 
carcinomas, the samples can be enriched for tumor cells 
by removing the surrounding healthy tissue. However, 
besides tumor epithelium with infiltrating cells, these 
macrodissected samples contain stroma cells as well. Evi­
dently, after RNA isolation of such macrodissected sam­
ples, tumor epithelium-derived RNA cannot be separated 
from RNA specific for stroma. Although informative, the 
presence of stroma might obscure the tumor cell gene 
expressions, thereby preventing accurate data on tumor 
cell expression profiles. Because in rectal carcinoma the 
percentages of stroma versus tumor epithelium vary 
widely among patients, this high variation might compli­
cate comparisons of different tumor samples even more.
To circumvent this problem, microdissection, such as 
Laser Microdissection and Pressure Catapulting (LMPC), 
can be used to select tumor epithelial cells exclusively. 
Although contamination of infiltrating cells will in this 
case also be present and important micro environmental 
information of the tumor cells will be missed, RNA 
extracted from such microdissected samples is expected to 
be more specific for tumor epithelial gene expression than 
RNA isolated from macrodissected samples. Comparisons 
of gene expression profiles of a small number of carci­
noma samples obtained using macrodissection or micro­
dissection, indeed led to the conclusion that stroma cells 
disturb the tumor gene expression profiles [5]. However, 
it has also been demonstrated that some degradation of 
RNA occurs during the lengthy procedure of laser capture 
microdissection, resulting in a decreased correlation 
between macro- and randomly microdissected samples
[6]. Another disadvantage of microdissection can be the 
limited amount of extracted RNA, requiring an extra 
amplification round to get sufficient RNA for microarray 
experiments. There are several publications addressing the 
effect of amplification on gene expression profiles. T7 
polymerase-based mRNA amplification is demonstrated 
to be reproducible and to maintain the relative abun­
dances of mRNA transcripts, although lower correlation 
coefficients are always observed when amplified samples 
are compared to non-amplified samples [7-9]. This ampli­
fication effect becomes more serious with less starting 
material, which is the case for microdissected samples. In
addition, a second round of amplification does have a fur­
ther effect on reproducibility [10,11].
In this study, we determined the most reliable way to 
detect the expression of tumor cell-derived genes by 
microarray analysis: macrodissection or microdissection. 
Comparing gene expression profiles of macrodissected 
and microdissected rectal carcinoma samples in the same 
experimental setting allowed evaluation of the effect of a 
second round of RNA amplification as well as evaluation 
of the presence of varying amounts of stroma. Quantifica­
tion of both effects demonstrated that the second amplifi­
cation round had a high impact on gene expression 
profiles. In addition, epithelial tumor cells as compared to 
stroma cells had a much higher contribution to gene 
expression profiles than is expected from the quantified 
surface percentage. We conclude that the obscuring effect 
of stroma on the tumor epithelium gene expression pro­
files appears to be minimal and that therefore in clinical 
settings the convenient procedure of macrodissection is 
the preferable method to examine rectal carcinomas by 
microarray analysis.
Results
Gene expression profiles o f macrodissected and 
microdissected rectal carcinomas
In the panel of excised rectal carcinoma samples used for 
this study, a high variation in surface percentages of tumor 
epithelium versus stroma was observed; percentages of 
epithelium ranged from 11 to 82% (Table 1). In order to 
compare macro- and microdissection of these carcinoma 
samples in microarray experiments, RNA was extracted
Table 1: Percentages epithelial tum or surface and used 
amplification scheme







1 1 1 1 2 nd
2 15 1, 2 2 2
3 17 1 2 2*
4 21 1 2 nd
5 35 1, 2 2 nd
6 37 1 2 nd
7 43 1 2 nd
8 50 1, 2 2 2
9 52 1 2 nd
10 59 1, 2 2 nd
11 59 1, 2 2 2
12 61 1 2 nd
13 71 1 2 nd
14 82 1, 2 2 2
* sample not used for microarray experiment because of insufficient 
aRNA after amplification.
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Figure 1
Unsupervised hierarchical clustering of macro- and microdissected rectal carcinoma samples. Macrodissected samples 
(squares), microdissected tumor epithelium samples (triangles) and microdissected stroma samples (circles) were clustered 
based on average correlation. Open symbols indicate RNA analyzed after one round of amplification and closed symbols indi­
cate two rounds of amplification. Numbers correspond to the carcinoma samples in Table 1.
from carcinoma tissue where surrounding healthy tissue 
had been removed (macrodissection), as well as from 
tumor epithelium isolated by LMPC (microdissection) of 
the same carcinoma samples. The microdissection proce­
dure of tumor epithelium resulted on average in 30 ng of 
total RNA. Because 1 |ig of mRNA is normally required for 
microarray experiments, two rounds of mRNA amplifica­
tion were necessary, yielding on average 15 |ig aRNA. For 
macrodissected samples one round of mRNA amplifica­
tion was sufficient to get an adequate amount of aRNA. To 
be able to examine the effect of the second round of 
mRNA amplification on the gene expression profiles, sev­
eral macrodissected samples were amplified a second 
round as well (Table 1).
All samples were Cy5-labeled and mixed with an equal 
amount of Cy3-labeled reference probe, consisting of 
equal amounts of RNA of all macrodissected samples. 
After hybridization of cDNA arrays, data were normalized 
and filtered, resulting in a set of 2358 genes that gave suf­
ficient signal on all arrays. Based on the expression of 
these 2358 genes, hierarchical clustering was performed 
to group samples according to similarity in gene 
expressions, without information of sample identity (Fig­
ure 1). This unsupervised clustering distinguished two 
main clusters according to the number of amplification 
cycles. Macrodissected samples that were amplified a sec­
ond round were more similar to twice-amplified micro­
dissected samples than to their original once-amplified 
samples. To determine the statistical significance of the 
effect of the second amplification cycle, Pearson correla-
Table 2: Effect o f the second round o f amplification. Pearson  
correlation  coefficients evaluating the effect o f the second round 
o f amplification on the gene expression profiles. Twice-amplified 
macrodissected samples w ere  com pared to the corresponding  
once-amplified m acrodissected samples. C o rre lation  o f duplicate  
amplification and labeling experim ents are presented as well. In 
case of repeated experim ents, Pearson correlation  coefficients 
w ere  calculated for each experim ent and averaged.









tion coefficients between once-amplified macrodissected 
samples and their corresponding twice-amplified samples 
were calculated. The resulting coefficients were low, in 
contrast to the coefficients of independently amplified 
samples or of duplicate labeling experiments (Table 2), 
excluding that such a change in expression profiles was 
induced by experimental variation.
Taken together, these findings indicate that, in this exper­
imental setting, expression profiles were hardly preserved
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during the extra round of amplification performed with 
random primers, and therefore exclude reliable cross­
comparison of once- and twice-amplified samples.
Evaluation o f the bias introduced by second round 
amplification
Low correlation coefficients indicate that the overall gene 
expression profile was changed. However, such coeffi­
cients do not specify whether the expression of all genes 
was slightly changed or whether the expression of a pro­
portion of genes was altered dramatically. To evaluate the 
amplification-induced change in more detail, the number 
of genes that were significantly preserved by the second 
round of amplification, a "conservative set of genes", was 
defined by t-tests according to Nygaard et al. [9]. These 
calculations indicated that 42% of the genes were on aver­
age not significantly influenced. Calculating a "rejected set 
of genes" indicated that for 20% of the genes the expres­
sions were significantly changed, and most of these 
rejected genes (70%) were changed at least three-fold. 
This suggests that a substantial proportion of the expres­
sion profile was significantly affected by the second round 
of amplification with random primers. However, closer 
examination of this "rejected gene-set" revealed that for 
the majority of the rejected genes, the amplification- 
induced change was in the same direction over all tumor 
samples, indicating that the bias for these genes could be 
constant. Although changed significantly, a constant bias 
might not influence the outcome as long as all tested sam­
ples are amplified for the same number of cycles.
To analyze whether the amplification-induced bias was 
constant for all carcinoma samples, we determined the 
actual variation for the whole set of 2358 genes. This var­
iation between once- and twice-amplified macrodissected 
samples is more indicative for the reproducibility of the 
amplification effect on the gene expression profiles. 
Therefore, the amplification-induced fold-changes of each 
gene were calculated for all tumor samples. These values 
were then averaged, which allow calculation of a standard 
deviation (SD) of the fold-change for each gene (Figure 
2). A high SD indicates that the amplification-induced 
change of that gene was less reproducible over the differ­
ent samples. For instance, the expression of a given gene 
may be induced ten-fold in one sample, while reduced 
ten-fold in the next sample. On average, the amplifica­
tion-induced change is zero, suggesting no effect. How­
ever, the variation of this particular gene among samples 
is 100-fold, which is too high to be regarded as reproduc­
ible. To determine which variation-range is acceptable, we 
used the 95% normal confidence interval, which is 
defined by the mean ± 1.96*SD. An interval with a ten­
fold variation-range has an SD of 0.25 on a log10-based 
scale, and an interval with a four-fold variation-range has 
an SD value of 0.15. Figure 2 demonstrates that several
0.6
0.0
-1.0 -0.5 0.0 0.5 1.0 1.5 2.0 
averaged fold-changes per gene 
(logi0-transformed data)
Figure2
Variation in amplification-induced fold-change for the con­
served and rejected gene-sets. Per gene the fold-change 
induced by the second round of amplification over all sam­
ples was averaged (x-axis) and plotted against the standard 
deviation (SD) of the fold-change (y-axis). Statistically con­
served genes (black) and rejected genes (gray) displayed high 
variation in standard deviations. A cut-off value at which the 
95% normal CI lies between 0.5 and 2 times the expression 
value (± 0.3 on log,0-scale) corresponds to an SD of 0.15 
(the 95% normal CI lies within 1.96 standard deviations of 
the mean; in this case SD = 0.3/1.96 = 0.15).
genes (8%) have a higher SD than 0.25, indicating that for 
these genes the amplification resulted in a highly dis­
persed (>ten-fold) expression pattern. When the cut-off 
point of the SD was set at 0.15, a range we propose to be 
acceptable, it turned out that 39% of all genes had a 
higher standard deviation. For this substantial proportion 
of genes, we concluded that the amplification effect was 
not constant over the different samples.
Larger contribution o f  tumor epithelium than stroma to 
gene expression profiles
In the unsupervised clustering (Figure 3) all twice-ampli­
fied samples clustered together. In this subgroup the 
macrodissected samples clustered closer to microdissected 
tumor samples than to stroma samples. This observation 
suggested that in general the effect of stroma on gene 
expression profiles of macrodissected samples was smaller 
than the contribution of tumor epithelium. To determine 
the contributions of epithelial tumor cells and of stroma 
cells in the gene expression profiles of macrodissected
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Table 3: Involvem ent o f tum or epithelium  and strom a. L inear regression was used to quantify the re lative contributions o f tum or  
epithelium  and strom a to the gene expression profile o f the macrodissected sample. If, for one gene, s is the am ount o f R N A  m easured  
in m icrodissected strom a, t  is the am ount m easured in m icrodissected tum or, and r is the am ount R N A  measured in the  
macrodissected sample, w e assume r = at+ fs, w here a a n d  f a r e  unknown coefficients. The last column is the re lative contribution of 
tum or epithelium , a/(a+ f), assuming that the contributions o f strom a and tum or together are 100%. Because w e  are considering a 
sum o f contributions on the linear R N A  scale, the regression has to be perform ed on the non-logged data. The values are averaged in 
case of duplicate labeling experim ents and standard erro rs o f coefficients a  and f  are given.
Sample surface %  epithelium tumor a  (std error) stroma ß (std error) relative tumor 
contribution: a/(a+ß)
2 15 0.44 (0.01) 0.46 (0.01) 49%
5 35 0.80 (0.01) nd nd
8 50 0.93 (0.01) 0.06 (0.02) 94%
10 59 0.91 (0.01) nd nd
1 1 59 0.66 (0.01) 0.14 (0.02) 83%
14 82 0.98 (0.02) 0.07 (0.03) 93%
samples, linear regression analysis was performed on the 
twice-amplified macrodissected samples with their corre­
sponding microdissected tumor and stroma samples 
(Table 3). In this analysis, the relationship between the 
macrodissected sample and the corresponding tumor and 
stroma samples were quantified according to the formula: 
gene expressions of macrodissected sample = a* tumor 
expressions + f*stroma expressions. The relative contribu­
tion of tumor epithelium can then be calculated by a/ 
(a+f). In case of carcinoma sample 14, with 18% stroma 
and 82% tumor epithelial surface in the macrodissected 
section, the relative contributions of stroma and tumor 
mRNA were 7% and 93%, respectively. For carcinoma 
sample 2, which had only 15% tumor epithelium surface 
in the macrodissected section, stroma and tumor mRNAs 
contributed equally to the gene expression profile of the 
macrodissected sample. These linear regression analyses 
demonstrate that the macrodissected gene expression pro­
file depends much more on the tumor epithelium than 
would be expected from the percentage of epithelial 
tumor surface.
The relatively high contribution of epithelial tumor cells 
suggested that more RNA could be extracted from tumor 
epithelium than from stroma. Therefore, the yields of 
total RNA isolated per volume microdissected tissue were 
compared (Figure 3). Although similar volumes of tumor 
epithelium and stroma were microdissected, yields of 
total RNA of epithelial tumor samples were on average 
3.5-fold higher than yields of stroma RNA (p = 0.001). 
This difference between tumor epithelium and stroma 
increased when the aRNA yields after two rounds of 
amplification were compared. On average, the amount of 
aRNA generated from microdissected tumor samples was 
eight times higher than the aRNA of equal volumes of 
stroma samples (p < 0.001). This difference in mRNA 
quantities explained the minor contribution of stroma to 
the gene expression profiles of macrodissected samples.
tumor stroma tumor stroma 
total RNA aRNA
Figure3
Total RNA and amplified RNA yields of equal volumes of 
microdissected tumor epithelium and stroma. The average 
yield of total RNA (left axis; closed symbols) isolated from 
tumor epithelium (triangles; mean 50 ng/mm2 of 10 |im thick 
sections), was higher than total RNA isolated from stroma 
(circles; mean 14 ng/mm2; p = 0.001). After two rounds of 
amplification, a higher difference was observed between 
yields of RNA (right axis; open symbols) of microdissected 
tumor epithelium (mean 33 |ig/mm2) and stroma (mean 4 |ig/ 
mm2; p < 0.0001).
Discussion
Surgically resected rectal carcinomas contain epithelial 
tumor cells as well as stroma cells. In microarray
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experiments of such specimens, both components will 
contribute to the gene expression profiles. The influence 
of stroma cells might therefore prevent accurate analysis 
of gene expressions specific for epithelial tumor cells, 
especially when high percentages of stroma are present in 
the carcinoma samples. For rectal carcinomas, the 
observed high variation in percentages of epithelial tumor 
surface might complicate interpretations of microarray 
data even more. Therefore, the question arose whether 
these samples had to be microdissected to obtain reliable 
tumor epithelial gene expression data.
In this study, we compared gene expression profiles of sev­
eral macrodissected rectal carcinoma samples, where only 
surrounding healthy tissue was removed, with the same 
samples microdissected by LMPC. Both the effect of a sec­
ond amplification round as well as the effect of stroma on 
the gene expression profiles was analyzed in order to 
determine the best dissection method to detect the expres­
sion of epithelial tumor-derived genes by microarray anal­
ysis. Unsupervised clustering of the gene expression 
profiles resulted in two main clusters according to the 
number of amplification rounds. This observation indi­
cates that the second round of amplification, needed for 
microdissected samples to get sufficient RNA for microar­
ray experiments, affected the overall gene expression 
profiles.
The T7 RNA polymerase-based linear amplification proto­
col [12] is one of the most widely used among the availa­
ble amplification techniques. In this procedure, the 
amplification reaction consists of transcription via an 
oligo(dT)-primer harboring a T7 promoter sequence. 
When second amplification rounds were required, as is 
the case for microdissected samples, an additional cDNA 
synthesis step was performed with second round primers 
followed by the T7-based amplification reaction. Because 
these second round primers are random primers, tran­
script sizes will decrease. Quality analysis of the amplified 
RNA samples demonstrated that indeed the second round 
of amplification slightly reduced transcript fragments 
(data not shown). This effect was more pronounced for 
microdissected samples, probably because of lower 
amounts of input RNA for the amplification procedure 
and some degradation occurring during the time-consum­
ing process of microdissection [6].
Most studies determined the amplification effect by com­
paring expression ratios of two non-amplified RNA sam­
ples versus the ratios of the same RNAs amplified. These 
studies show that the majority of expression differences 
were maintained by the amplification procedure although 
a slight decrease in correlation coefficients was observed 
[13,14], and the intensity levels were not preserved 
[7,9,15]. In order to evaluate macro- versus
microdissection, we determined the effect of the for 
microdissection required second amplification reaction 
on the gene expression profiles by comparing once- and 
twice-amplified samples. The low Pearson correlation 
coefficients and the calculated significantly "conserved" 
and "rejected" gene-sets according to Nygaard et al. [9] 
demonstrate that the overall gene expression profile was 
changed by the second round of amplification. In this 
cross-comparison analysis, the extreme low correlation 
coefficients might be the consequence of the above-sug­
gested loss of intensity levels.
Such a cross-comparison analysis of once- and twice- 
amplified samples indicates that the gene expression pro­
file is changed by the amplification reaction, but not 
whether this change is reproducible for all samples. Other 
studies established that amplification-induced changes 
are particularly sequence dependent and not abundance 
dependent [10,15], suggesting a fairly constant bias. 
Therefore, the variation of the amplification-induced 
change over the different samples was determined, as this 
variation will be indicative for the consistency of the bias. 
When we take a standard deviation of 0.15 as an approxi­
mate quantitative criterion (95% normal confidence 
interval, allowing a four-fold variation in expressions 
induced by amplification), for 39% of the genes the vari­
ation in the gene expression introduced by amplification 
was outside this confidence interval. This analysis indi­
cates that for a substantial proportion of the genes, the 
amplification-induced change was not constant.
Importantly, such a high variation was observed with sim­
ilar frequencies in the "conserved" and "rejected" gene­
sets. Therefore, although twice-amplified genes might be 
called "conserved" based on a t-test, indicating that the 
change on average is around zero, the variation over the 
different samples will be changed by the amplification, 
resulting in more false-negative and false-positive genes. 
Since genes extracted from the microarray analysis require 
verification by other biochemical experiments, false-posi­
tive genes will be recognized and can be reclassified. Puta­
tive interesting genes that are false negative will be missed 
from the analysis.
Since the second round of amplification affected the gene 
expression profiles, the use of once-amplified samples is 
highly preferred. The fact that for macrodissected samples 
one round of amplification suffices to get enough labeled 
mRNA, which results in a far more convenient and cost- 
effective procedure [16], supports the use of macrodis­
sected samples. Although the first amplification round 
might induce some changes in gene expression as well, the 
amplification-induced bias is reported to be larger when 
the amounts of input material is low [10,17]. The yields of 
RNA isolated from microdissected samples were small,
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while for macrodissected samples the recommended 
quantity of 1 |ig total RNA could be used in the amplifica­
tion reaction. Therefore, the amplification-induced bias is 
probably slightly higher for microdissected samples than 
for macrodissected samples. Of note, one round of ampli­
fication is demonstrated to be more sensitive to low abun­
dance transcripts than using total RNA [18-20].
A possible disadvantage of macrodissected samples is the 
presence of stroma cells that might disturb the epithelial 
tumor-specific gene expression profiles. We therefore 
evaluated the contribution of stroma in the macrodis­
sected gene expression profiles. In the unsupervised clus­
tering of twice-amplified samples, macrodissected 
samples clustered closer to microdissected tumor samples 
than to microdissected stroma samples, suggesting that 
epithelial tumor cells had a higher contribution to gene 
expression profiles than stroma cells. This observation 
was confirmed by linear regression analysis, indicating 
that the involvement of stroma in macrodissected gene 
expression profiles was minor. In the unsupervised clus­
tering, samples 2 and 14 (low en high percentage of tumor 
epithelium, respectively) clustered relatively together with 
their corresponding microdissected stroma and tumor 
sample. Although this observation suggested an associa­
tion between the surface percentage of tumor epithelium 
in the macrodissected sample and the degree of clustering 
of this sample with the microdissected tumor sample, 
such a clear-cut correlation could not be established. The 
contribution of stroma to the gene expression profiles was 
not strictly related to the surface percentage and was 
smaller than expected from the surface percentage of the 
stroma. However, for the sample with 15% tumor epithe­
lium the contributions of stroma and tumor were equal, 
indicating that this sample contained probably too much 
stroma for adequate analysis of tumor-derived genes. For 
such samples a further enrichment for tumor epithelium 
is necessary and can probably be attained by 
macrodissection.
An explanation for our finding that the contribution of 
stroma is relatively small is provided by the observation 
that the yields of total RNA as well as of amplified mRNA 
from stroma samples were much lower than from equal 
volumes of tumor tissue. These findings are presumably 
due to a higher density of tumor cells and/or more tran­
scription activity in tumor epithelium compared to 
stroma. Although these data are obtained by analysis of 
rectal carcinoma samples, our conclusions are probably 
applicable to other tumor types with a stroma component 
as well. The fact that far less mRNA is isolated from stroma 
than from epithelium suggests that the contribution of 
stroma to the overall gene expression profile will always 
be minor with the consequence that macrodissection 
might be the preferred method for other carcinoma types
as well. Furthermore, in case it is absolutely necessary to 
discard the stroma gene expression, it might be an option 
to perform in silico microdissection [21-23]. These compu­
tational approaches have the advantage that 
macrodissected samples can be used, thereby leaving out 
the biases caused by the required second round of ampli­
fication in case of manual microdissection. However, it is 
important to realize that most of the in silico approaches 
are based on the assumption that tumor epithelium and 
stroma will equally contribute to the overall gene expres­
sion profile. In this study, we demonstrated that the 
stroma contribution is much smaller than expected from 
the surface area of the rectal carcinoma sample, which 
should be included in the in silico analysis.
Although the influence of stroma-derived RNA on the 
expression profiles of genes which are expressed by 
stroma as well as by tumor epithelium is small, expression 
of genes which are specific for stroma cells, might still be 
detectable when using macrodissection [24]. This is an 
additional advantage of macrodissection, because 
increasing evidence supports an important role for the 
microenvironment in carcinoma formation and progres­
sion, and therefore these stroma cells might be of great 
interest. For instance, expression of some stroma-specific 
genes appeared to be correlated with patient prognosis 
[2,25]. Fromique et al. [26] showed that signaling 
between epithelial tumor cells and fibroblasts influenced 
the gene expression pattern of the tumor cells. For rectal 
carcinoma it has been demonstrated that apart from the 
pathological characteristics of tumor cells the amount and 
type of infiltrate is also relevant for the control of cancer
[27]. When tumor epithelium is selected by LMPC, this 
stroma-specific information is missed.
Conclusion
Because rectal carcinoma samples contained varying 
amounts of stroma versus tumor epithelium, the question 
arose whether macrodissection could be used or whether 
the samples should be microdissection for gene expres­
sion profiling. Purification of tumor epithelium by laser 
microdissection was supposed to give the most reliable 
tumor-specific gene expression profiles. However, we 
showed that these overall gene expression profiles are 
affected by the required second round of mRNA amplifi­
cation with random primers. The contribution of stroma 
to gene expression profiles of macrodissected samples was 
much smaller than expected on the basis of the quantified 
surfaces. And of even more importance, the interference of 
stroma cells with the overall gene expression profiles 
appeared to be minor. Therefore, we recommend RNA 
isolation of clinically resected carcinomas samples that 
are only enriched for tumor epithelium by macrodissec­
tion for microarray experiments.
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Figure4
Schematic overview of the strategy used to compare macro­
dissection and microdissection. All 14 rectal carcinoma sam­
ples are macrodissected or microdissected for tumor 
epithelium, 6 macrodissected samples were in addition ampli­
fied (amp) a second round and of 4 samples the stroma was 
microdissected as well.
Methods
Macrodissection and microdissection o f  tissue samples
The experimental outline of this study is depicted in Fig­
ure 4. Fresh frozen rectal carcinoma samples were 
obtained from 14 different patients who underwent 
surgery in either the Leiden University Medical Center or 
the Leyenburg Hospital. All samples were macrodissected 
in a cryostat at -20°C by removing surrounding healthy 
tissue. Of these, two sections of 30 |im were collected for 
total RNA extraction. For the microdissection procedure
[28], sections of 10 |im were cut and adhered to polyeth- 
ylene-naphtalate (PEN) membrane slides (P.A.L.M. 
Microlaser Technologies AG, Bernried, Germany), fol­
lowed by hydration by rinsing the slides in 100%, 75% 
and 50% ethanol. The samples were stained with Mayer's 
haematoxylin, briefly rinsed in diethylpyrocarbonate 
(DEPC)-treated water and dehydrated in graded ethanols. 
All slides were finally air-dried and stored dry at -80°C 
until microdissection was performed using the PALM® 
Micro Beam microscope (P.A.L.M. Microlaser Technolo­
gies AG) for non-contact laser microdissection and pres­
sure catapulting (LMPC). Microdissection of 0.5-1 mm2 
tissue took 30 to 120 minutes per sample.
Sections of 5 |im of each macrodissected sample were 
stained with classical haematoxylin and eosin staining 
and examined by light microscopy to quantify the surface 
percentages of tumor epithelium versus stroma. Table 1 
gives an overview of the samples used and the quantified 
percentages of tumor epithelium.
Total RNA extraction, mRNA amplification and labeling
For macrodissected samples, the sections were homoge­
nized by vortexing with glass beads in RNA-Bee reagent 
(Tel-Test Inc., Friendswood, TX). Total RNA was extracted 
according to the manufacturer's protocol of RNA-Bee and 
purified using the Qiagen RNeasy mini kit with on-col- 
umn DNase digestion according to manufacturer's 
instructions (Qiagen Sciences, Germantown, MD). For 
microdissected tissues, total RNA was isolated using the 
Qiagen RNeasy mini kit with on-column DNAse treat­
ment (Qiagen). Quality of total RNAs was assessed with 
lab-on-a-chips on the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Palo Alto, California). All samples were 
shown to be free of DNA contamination and for each 
sample the ratio 28S/18S was >1.5.
Amplifications were performed using Ambion's Mes- 
sageAmp™ kit and protocol (Ambion Inc., Austin, TX). For 
macrodissected samples, of which on average 30 |ig total 
RNA was isolated, the first amplification round was 
started with 1.0 |ig total RNA. This first amplification 
round of macrodissected samples yielded on average 24 
|ig amplified mRNA (aRNA). The second round of ampli­
fication, using random second round primers, was started 
with 1.0 |ig aRNA in case of macrodissected samples. For 
microdissected specimens the whole quantity of isolated 
total RNA was used (on average 30 ng total RNA) for the 
first round of amplification, and all aRNA was used for the 
second round of amplification. Yield of aRNA of these 
twice-amplified microdissected samples was on average 
15 |ig aRNA. Quality of each aRNA was checked on lab- 
on-a-chip (Agilent Technologies). Quantification of aRNA 
was performed by spectrometry at 260 nm wavelength.
Per microarray experiment, 1.0-|ig aliquots of aRNA were 
labeled with Cy5-dUTPs (Amersham Biosciences, Buck­
inghamshire, UK) by direct incorporation during a reverse 
transcriptase reaction using the CyScribe kit, according to 
manufacturer's instructions (Amersham Biosciences). The 
labeled cDNAs were mixed with equal amounts of Cy3- 
dUTP-labeled cDNA from a once-amplified reference 
probe, consisting of equal amounts of RNA from all mac­
rodissected samples.
cDNA microarray
The mixture of labeled reference and sample was purified 
on YM30 Microcon columns (Millipore Corporation, 
Bedford, MA) together with 20 |ig human COT-1 DNA
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(Invitrogen, Carlsbad, CA). After purification, 8 |ig yeast 
tRNA (Invitrogen) and 20 |ig polyadenylic acid (Sigma- 
Aldrich, St. Louis, MO) were added. Preheated hybridiza­
tion buffer (25% formamide, 5x SSC, 0.1% SDS) was 
added just before hybridization at 42°C o/n in to human 
18K cDNA microarrays slides, manufactured at the Cen­
tral Microarray Facility (CMF) of the Netherlands Cancer 
Institute. Protocols, GeneID list and information about 
arrays are available at the website of the CMF [29].
Data preparation
Of each slide, two images were scanned using the 
GeneTAC LSIV laser scanner (Genomic Solutions, Ann 
Arbor, MI) at different gain settings, one at which hardly 
any of the spots were saturated and one with a higher gain 
to obtain data from lowly expressed genes. Spots were 
quantified by using GenePix Pro 4.1 software (Axon 
Instruments Inc., Union City, CA). For spot selection an 
MS-Excel macro was used [30]. Briefly: spots were cor­
rected for local background noise. Per dye, the intensity of 
each spot was normalized to the median of all spots on 
the array and for each spot, the ratio of the sample to the 
reference was calculated. Because arrays were scanned at 
two different settings, ratios from high gain-saturated 
spots were used from the low gain scans, while lowly 
expressed genes were used from the high gain scans. 
Genes saturated in both gains were rejected from analysis. 
For other spots, the mean of the ratios of the two scans 
was calculated. Finally, ratios were log10-transformed. 
Because the goal of this study was to analyze the effects of 
macro- and microdissection on overall gene expression 
profiles and not to select specific genes, only qualified 
genes that were present on all 45 arrays (2358 genes) were 
selected for further statistical analyses. The data discussed 
in this publication have been deposited in NCBIs Gene 
Expression Omnibus (GEO) [31] and are accessible 
through GEO Series accession number GSE2738.
Array data analysis
Unsupervised clustering of the genes and samples was per­
formed with Spotfire 7.2 software (Spotfire AB, Goteborg, 
Sweden) based on hierarchical clustering of average link­
age correlation of the log10-transformed data. Pearson cor­
relation coefficients and linear regression were calculated 
with SPSS 11.0 software for Windows (SPSS Inc., Chicago, 
IL). The "conservative" and "rejected" gene sets were cal­
culated according to Nygaard et al. [9]. In summary, for 
the "conservative set of genes", each gene with a p-value 
less than 0.1 in a t-test assuming unequal variances or in 
a t-test assuming equal variances was removed. The 
"rejected set of genes" are genes which are significantly 
changed when two groups of samples are compared in a t- 
test according to the Benjamini-Hochberg procedure [32] 
with a false discovery rate of 1%.
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